WATCH NOW
PTC Therapeutics Webinar | January 2025
On January 21, 2025, PTC Therapeutics CEO Matthew B. Klein, M.D., joined the FA community and FARA CEO Jen Farmer, M.S., to share the latest updates on the vatiquinone program for Friedreich’s ataxia. The full recording is available for viewing.